ES2164702T3 - Purificacion de proteinas plasmaticas. - Google Patents
Purificacion de proteinas plasmaticas.Info
- Publication number
- ES2164702T3 ES2164702T3 ES94915731T ES94915731T ES2164702T3 ES 2164702 T3 ES2164702 T3 ES 2164702T3 ES 94915731 T ES94915731 T ES 94915731T ES 94915731 T ES94915731 T ES 94915731T ES 2164702 T3 ES2164702 T3 ES 2164702T3
- Authority
- ES
- Spain
- Prior art keywords
- waterproof
- protein
- viruses
- inactivating
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 238000000746 purification Methods 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 3
- 239000003599 detergent Substances 0.000 abstract 3
- 230000000415 inactivating effect Effects 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
- C07K1/303—Extraction; Separation; Purification by precipitation by salting out
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8125—Alpha-1-antitrypsin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
ESTA INVENCION SE REFIERE A UN PROCESO PARA LA REDUCCION DE LAS SUSTANCIAS QUIMICAS INACTIVADORAS DE VIRUS Y/O DETERGENTES EN UNA COMPOSICION ACUOSA QUE CONTIENE UNA PROTEINA DEL PLASMA SOLUBLE EN AGUA. MEDIANTE LA SELECCION DE UNA COMBINACION ADECUADA DE TEMPERATURA Y CONCENTRACION POR ENCIMA DE 0,5 M DE UNA SAL CON ALTO EFECTO DE PRECIPITACION POR LA ADICION DE SAL SEGUN LA SERIE HOFMEISTER, SE FORMAN VESICULAS QUE CONTIENEN LA SUSTANCIA QUIMICA INACTIVADORA DE VIRUS Y/O DETERGENTE. ESTAS VESICULAS SE SEPARAN DE LA FASE ACUOSA, EJ. MEDIANTE UNA SEPARACION DE FASE O FILTRACION Y DESPUES SE AISLA LA PROTEINA DE LA FASE ACUOSA. LA PROTEINA DEL PLASMA SOLUBLE EN AGUA PUEDE SER P. EJ. ANTITROMBINA III, TRANSFERINA O ALBUMINA. CUANDO LA FASE ACUOSA CONTIENE P. EJ. UNA SAL DE CITRATO O SULFATO EN UNA CONCENTRACION SUPERIOR A 1 M A TEMPERATURA AMBIENTE, LA REDUCCION DE LA SUSTANCIA QUIMICA INACTIVADORA DE VIRUS O DETERGENTES PUEDE SER HASTA 2000 VECES O MAS, CON LO QUE SE OBTIENE UNA CONCENTRACION FINAL INFERIOR A 5 PPM.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE19939301582A SE9301582D0 (sv) | 1993-05-07 | 1993-05-07 | Purification of plasma proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2164702T3 true ES2164702T3 (es) | 2002-03-01 |
Family
ID=20389869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94915731T Expired - Lifetime ES2164702T3 (es) | 1993-05-07 | 1994-05-06 | Purificacion de proteinas plasmaticas. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5817765A (es) |
| EP (1) | EP0700300B1 (es) |
| JP (1) | JP3771935B2 (es) |
| AT (1) | ATE205719T1 (es) |
| AU (1) | AU677332B2 (es) |
| CA (1) | CA2161804C (es) |
| DE (1) | DE69428356T2 (es) |
| DK (1) | DK0700300T3 (es) |
| ES (1) | ES2164702T3 (es) |
| FI (1) | FI113779B (es) |
| NO (1) | NO313084B1 (es) |
| NZ (1) | NZ266234A (es) |
| PT (1) | PT700300E (es) |
| SE (1) | SE9301582D0 (es) |
| WO (1) | WO1994026287A1 (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9500724D0 (sv) | 1994-06-23 | 1995-02-24 | Pharmacia Ab | Filtrering |
| ES2099678B1 (es) * | 1995-11-03 | 1998-02-16 | Grifols Grupo Sa | Procedimiento para la inactivacion de virus en proteinas. |
| SE9902388D0 (sv) * | 1999-06-23 | 1999-06-23 | Pharmacia & Upjohn Ab | Method for purification of proteins |
| US6518406B1 (en) | 1999-06-23 | 2003-02-11 | Octapharma Ag | Method for purification of proteins |
| DE19932782A1 (de) * | 1999-07-14 | 2001-01-18 | Biotest Pharma Gmbh | Verfahren zur chromatographischen Fraktionierung von Plasma oder Serum, so erhaltene Präparate und deren Verwendung |
| WO2001045719A1 (fr) * | 1999-12-20 | 2001-06-28 | Mitsubishi Pharma Corporation | Compositions a base de proteines de plasma exemptes de virus traitees a l'aide d'une membrane poreuse et procede de production |
| UA86775C2 (ru) * | 2003-08-12 | 2009-05-25 | Октафарма Аг | Способ очистки раствора альфа-1-антитрипсина |
| WO2006011161A2 (en) * | 2004-06-29 | 2006-02-02 | Reliance Life Sciences Pvt Ltd | Process for the preparation of virus-safe biological fluids |
| AU2005229674B2 (en) * | 2004-11-18 | 2010-11-04 | Kedrion Melville Inc. | Low concentration solvent/detergent process of immuneglobulin with pre-treatment |
| US20100136584A1 (en) * | 2008-09-22 | 2010-06-03 | Icb International, Inc. | Methods for using antibodies and analogs thereof |
| US20100092470A1 (en) * | 2008-09-22 | 2010-04-15 | Icb International, Inc. | Antibodies, analogs and uses thereof |
| DK2350271T3 (en) | 2008-11-20 | 2016-04-04 | Biogen Ma Inc | ARGININ INACTIVATION OF ENVIRONMENT VIRA |
| CN102812118B (zh) * | 2010-04-08 | 2016-01-20 | 恰根有限公司 | 分离和纯化核酸的方法 |
| EP2395082A1 (en) | 2010-06-14 | 2011-12-14 | QIAGEN GmbH | Extraction of nucleic acids from wax-embedded samples |
| US8921062B2 (en) | 2010-11-09 | 2014-12-30 | Quest Diagnostics Investments Incorporated | Diagnostic and prognostic assays based on circulating tyrosine kinase activity |
| US10112988B2 (en) | 2012-01-09 | 2018-10-30 | Icb International, Inc. | Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide |
| US10112987B2 (en) | 2012-01-09 | 2018-10-30 | Icb International, Inc. | Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide |
| JP6370792B2 (ja) * | 2012-10-03 | 2018-08-08 | ツェー・エス・エル・ベーリング・アクチエンゲゼルシャフト | タンパク質の精製方法 |
| US9534029B2 (en) | 2012-10-03 | 2017-01-03 | Csl Behring Ag | Method of purifying proteins |
| CA3149777A1 (en) * | 2019-09-20 | 2021-03-25 | Eugene ZURLO | Therapeutic protein compositions and methods |
| US10815270B1 (en) * | 2019-09-20 | 2020-10-27 | Plasma Technologies, Llc | Compositions and methods for high efficiency protein precipitation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820805A (en) * | 1983-07-14 | 1989-04-11 | New York Blood Center, Inc. | Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives |
| US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
| US4764369A (en) * | 1983-07-14 | 1988-08-16 | New York Blood Center Inc. | Undenatured virus-free biologically active protein derivatives |
| US4684723A (en) * | 1985-09-11 | 1987-08-04 | Miles Laboratories, Inc. | Method of separating proteins from aqueous solutions |
| US4789545A (en) * | 1986-03-31 | 1988-12-06 | New York Blood Center, Inc. | Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof |
| EP0367840B1 (de) * | 1988-11-05 | 1993-02-03 | Octapharma AG | Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie |
| US5395923A (en) * | 1993-02-23 | 1995-03-07 | Haemacure-Biotech, Inc. | Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out" |
-
1993
- 1993-05-07 SE SE19939301582A patent/SE9301582D0/xx unknown
-
1994
- 1994-05-06 ES ES94915731T patent/ES2164702T3/es not_active Expired - Lifetime
- 1994-05-06 AT AT94915731T patent/ATE205719T1/de active
- 1994-05-06 DK DK94915731T patent/DK0700300T3/da active
- 1994-05-06 CA CA002161804A patent/CA2161804C/en not_active Expired - Fee Related
- 1994-05-06 JP JP52470494A patent/JP3771935B2/ja not_active Expired - Fee Related
- 1994-05-06 US US08/537,872 patent/US5817765A/en not_active Expired - Lifetime
- 1994-05-06 WO PCT/SE1994/000422 patent/WO1994026287A1/en active IP Right Grant
- 1994-05-06 PT PT94915731T patent/PT700300E/pt unknown
- 1994-05-06 AU AU67634/94A patent/AU677332B2/en not_active Ceased
- 1994-05-06 NZ NZ266234A patent/NZ266234A/en not_active IP Right Cessation
- 1994-05-06 DE DE69428356T patent/DE69428356T2/de not_active Expired - Lifetime
- 1994-05-06 EP EP94915731A patent/EP0700300B1/en not_active Expired - Lifetime
-
1995
- 1995-11-06 NO NO19954428A patent/NO313084B1/no not_active IP Right Cessation
- 1995-11-06 FI FI955306A patent/FI113779B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0700300A1 (en) | 1996-03-13 |
| DK0700300T3 (da) | 2001-12-31 |
| FI955306A (fi) | 1995-11-06 |
| EP0700300B1 (en) | 2001-09-19 |
| SE9301582D0 (sv) | 1993-05-07 |
| NO954428L (no) | 1995-11-06 |
| CA2161804A1 (en) | 1994-11-24 |
| JPH08509746A (ja) | 1996-10-15 |
| JP3771935B2 (ja) | 2006-05-10 |
| PT700300E (pt) | 2002-03-28 |
| FI955306A0 (fi) | 1995-11-06 |
| AU677332B2 (en) | 1997-04-17 |
| DE69428356T2 (de) | 2002-04-25 |
| NZ266234A (en) | 1996-06-25 |
| WO1994026287A1 (en) | 1994-11-24 |
| NO954428D0 (no) | 1995-11-06 |
| ATE205719T1 (de) | 2001-10-15 |
| AU6763494A (en) | 1994-12-12 |
| FI113779B (fi) | 2004-06-15 |
| US5817765A (en) | 1998-10-06 |
| DE69428356D1 (de) | 2001-10-25 |
| NO313084B1 (no) | 2002-08-12 |
| CA2161804C (en) | 2003-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2164702T3 (es) | Purificacion de proteinas plasmaticas. | |
| KR860008276A (ko) | 단백질이 생성된 배양기로 부터 그것을 추출, 정제하는 방법 | |
| DK1075488T3 (da) | Proteinoprensning ved ionbytningskromatografi | |
| DE69001164D1 (de) | Behandlungsverfahren durch elektrische entionisierung und uv-licht zur reinigung von wasser. | |
| DK0775150T3 (da) | Fremgangsmåde til reduktion eller fjernelse af endotoksiner | |
| MX147019A (es) | Mejoras en sistema de soldadura por arco | |
| PT98193A (pt) | Estojo para a dosagem especifica de angiotensina ii | |
| FR2422720A2 (fr) | Separation et purification de proteines par chromatographie | |
| JPS5359254A (en) | Method of purifying waste liquid produced from photographic treatment using sulfur bacteria and method of recoveryof silver from waste liquid of photographic treatment | |
| FR2565991B1 (fr) | Procede de valorisation d'essences olefiniques par etherification | |
| FI915811A0 (fi) | Menetelmiä mikrobiologisesti tuotetun kymosiinin talteenottamiseksi | |
| DE69902639D1 (de) | Verbessertes verfahren zur herstellung von faktor viii | |
| FR2433812B1 (fr) | Procede de purification d'eaux residuaires contaminees, contenant des agents tensio-actifs et detergents | |
| DK164916C (da) | Fremgangsmaade til rensning eller berigelse af biologisk aktive proteiner og hertil egnet middel | |
| DE69326147D1 (de) | Dampfsterilisierbares system zur inaktivierung viraler verunreinigungen in körperflüssigkeiten | |
| NO885491D0 (no) | Fremgangsmaate for reduksjon av avleiringer i anlegg for inndampning av sulfittavlut. | |
| ES2164445T3 (es) | Procedimiento para la obtencion de soluciones acuosas de hidroxilamina de gran pureza. | |
| DE69715883D1 (de) | Stabilisierung von interferonen in wässriger lösung durch gummiarabikum | |
| SE7906137L (sv) | Rening av faktor viii | |
| DE69604390D1 (de) | Uv-reflektor, integriert in eine uv-anlage zur gas- oder flüssigkeitsreinigung, bevorzugt von wasser | |
| JPS559036A (en) | Purification of igm | |
| ES2131827T3 (es) | Aparato para la descontaminacion de suelos que contienen metales pesados. | |
| SU568603A1 (ru) | Способ очистки сточных вод от меди | |
| ES2135455T3 (es) | Procedimiento de purificacion de proteinas a partir de sistemas celulares. | |
| AR007308A1 (es) | Composiciones liquidas de fase estable para refrescar telas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 700300 Country of ref document: ES |